Pediatric Cardiology

, Volume 32, Issue 2, pp 176–182 | Cite as

The 30-Year Outcome for Patients After Myocardial Infarction Due to Coronary Artery Lesions Caused By Kawasaki Disease

  • Etsuko TsudaEmail author
  • Takuya Hirata
  • Osamu Matsuo
  • Tadaaki Abe
  • Hisashi Sugiyama
  • Osamu Yamada
Original Article


This study determined the long-term outcome for patients after myocardial infarction (MI) due to Kawasaki disease (KD). Retrospective analysis was performed for 60 patients who had experienced MI between 1976 and 2007. Their ages at the initial MI ranged from 3 months to 33 years (median, 2 years). The maximum follow-up period after the initial MI was 33 years (median, 16 years). Coronary angiography, left ventriculography, and radioisotope myocardial perfusion imaging (MPI) had been performed for 56 patients more than 2 months after MI when all were in stable condition. The survival rate and ventricular tachycardia (VT)-free survival rate were calculated after the initial MI by the Kaplan–Meier method. Both sustained and nonsustained VT were included. Furthermore, the Cox proportional hazards model was used to analyze which factors influenced the post-MI outcome and which influenced the appearance of VT. The 30-year survival rate was 62.7% (95% confidence interval [CI], 44.6–77.9%), and the 25-year VT-free survival rate after MI was 28.5% (95% CI 15.4–46.5%). The postinfarction left ventricular ejection fraction (LVEF) was related to the outcome in this population (hazard ratio 0.86; 95% CI 0.75–0.95; P = 0.002), whereas the development of VT was related to the post-LVEF and to perfusion abnormalities in MPI (P = 0.0002). The 30-year survival rate after MI was poor for the patients with a low LVEF. With aging, the existence of nonviable myocardium in the infarct area can induce fatal ventricular arrhythmia more than 10 years after the original MI.


Acute myocardial infarction Kawasaki disease Myocardial perfusion imaging Sudden death Thrombolysis Ventricular tachycardia 



We thank Professor Peter Olley for his kind English language consultation.


  1. 1.
    Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Eng J Med 341:1882–1890CrossRefGoogle Scholar
  2. 2.
    Doughty RN, Whalley GA, Walsh HA, Gamble GD, Sendon JL, Sharpe N, on behalf of the CAPRICORN Echo Substudy Investigators (2004) Effects of Carvedilol on left ventricular remodeling after acute myocardial infarction. The CAPRICORN Echo Substudy. Circulation 109:201–206CrossRefPubMedGoogle Scholar
  3. 3.
    Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108:923–927CrossRefPubMedGoogle Scholar
  4. 4.
    Keeley E, Boura JA, Grines CL (2006) Comparison of primary and facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: quantitative review of randomized trials. Lancet 367:579–588CrossRefPubMedGoogle Scholar
  5. 5.
    Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, O’Neill WW, Grines CL (2004) Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 43:1773–1779CrossRefPubMedGoogle Scholar
  6. 6.
    Kober L, Pedrsen CT, Bagger H, Eliasen P, Lyngborg K, Aliot E, Persson S, Camm J, for the Trandolapril Cardiac Evaluation (TRACE) study group (1995) A clinical trial of angiotensin-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Eng J Med 333:1670–1676CrossRefGoogle Scholar
  7. 7.
    Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T (2002) Mortality among patients with a history of Kawasaki disease: the third look. Acta Paediatr Jpn 156:162–165Google Scholar
  8. 8.
    Nakamura Y, Yashiro M, Uehara R et al (2008) Epidemiologic features of Kawasaki disease in Japan: results from the national survey in 2005–2006. J Epidemiol 18:167–172CrossRefPubMedGoogle Scholar
  9. 9.
    Pogwizd SM (1994) Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation 90:1441–1448PubMedGoogle Scholar
  10. 10.
    Roberman W, Weinblatt E, Goldberg JD, Frank CW, Chaudhary BS, Shapiroo S (1981) Ventricular premature complexes and sudden death after myocardial infarction. Circulation 64:297–305Google Scholar
  11. 11.
    Shrir T, Germano G, Kavanagh PB et al (1999) Incremental prognostic value of poststress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100:1035–1042Google Scholar
  12. 12.
    Tsuda E (2009) Coronary artery bypass grafting for coronary artery stenosis caused by Kawasaki disease. Expert Rev Cardiovasc Ther 7:533–539CrossRefPubMedGoogle Scholar
  13. 13.
    Tsuda E, Kitamura S, Cooperative Study Group of Japan (2004) National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 110(Suppl 1):II61–II66Google Scholar
  14. 14.
    Tsuda E, Arakaki Y, Shimizu T et al (2005) Changes in causes of sudden deaths in patients with coronary arterial lesions due to Kawasaki disease. Cardiol Young 15:1–8CrossRefGoogle Scholar
  15. 15.
    Tsuda E, Matsuo M, Kurosaki K et al (2007) Clinical features of patients diagnosed as coronary artery lesions caused by presumed Kawasaki disease in adults. Cardiol Young 17:84–89CrossRefPubMedGoogle Scholar
  16. 16.
    Yagi S, Tsuda E, Shimizu W et al (2005) Two adults requiring implantable defibrillators because of ventricular tachycardia and left ventricular dysfunction caused by presumed Kawasaki disease. Circ J 69:870–874CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Etsuko Tsuda
    • 1
    Email author
  • Takuya Hirata
    • 1
  • Osamu Matsuo
    • 1
  • Tadaaki Abe
    • 1
  • Hisashi Sugiyama
    • 1
  • Osamu Yamada
    • 1
  1. 1.Department of Pediatric CardiologyNational Cerebral and Cardiovascular CenterOsakaJapan

Personalised recommendations